Novartis forge deal with Boston Pharmaceuticals in effort against AMR
October 3, 2018Research and Development AMR, Antibiotics, Boston Pharmaceuticals, Novartis, US
Swiss multinational Novartis have entered into a licensing and equity agreement with Boston Pharmaceuticals for the development of three novel …
Memorial Sloan Kettering Chief resigns from MSD board
October 3, 2018Research and Development MSD, Memorial Sloan Kettering Cancer Center, pharma
Dr Craig Thompson, Chief Executive of Memorial Sloan Kettering Cancer Center (MSKCC), the renowned non-profit treatment and research institution based …
Clinical trial halted because of Brexit, UK Government downplays concerns
October 3, 2018Research and Development UK, brexit, clinical trials, politics, research
A clinical trial looking into the safety and efficacy of the drug dutogliptin has been halted due to uncertainties surrounding …
No link between progression-free survival benefits and improved quality of life, study argues
October 2, 2018Manufacturing and Production, Research and Development Cancer, clinical trials, pharma
A study of randomised clinical trials, conducted by Canada’s McMaster University and published in the Journal of the American Medical …
African-American enrollment disproportionately high in no-consent trials
October 2, 2018Manufacturing and Production, Research and Development FDA, clinical trials, pharma, transparency
A new study has revealed that African-American citizens make up a disproportionately high share of participants in US clinical trials …
20 year old man died after leukaemia cell was accidently mixed into CAR T therapy
October 2, 2018Manufacturing and Production CAR T, CAR-T, Cancer, Kymriah, Novartis, leukaemia, oncology
A 20 year old man died after a single leukaemia cell accidentally ended up in a batch of cells that …
Nobel Prize awarded to immuno-oncology innovators
October 2, 2018Manufacturing and Production Cancer, Nobel Prize, immunotherapy, kyoto, oncology, texas
The Nobel Prize for physiology or medicine has been awarded to both Professor James P Allison and Tasuku Honjo for …
Pfizer CEO Ian Read set to step down from head position
October 1, 2018Manufacturing and Production, Sales and Marketing Albert Bourla, CEO, COO, Ian Read, Pfizer, Stock Markets
Ian Read is set to step down from his position as Chief Executive Officer (CEO) of American pharma firm Pfizer, …
Are biosimilars key to solving NHS access concerns?
October 1, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, Pfizer, UK, biosimilars, celltrion, pharma
In light of continued austerity gripping the NHS, it was uplifting to hear in July that the health service had …
European countries unprepared for Alzheimer’s innovations, study shows
October 1, 2018Sales and Marketing Alzheimer's dementia, Alzheimer’s & dementia, EU, Euroepan Union, RAND corporation, research
European healthcare systems are not prepared for new developments in preventative therapies for Alzheimer’s disease, according to research conducted by …
NHS England to fund availability of Janssen’s single tablet HIV combo Symtuza
October 1, 2018Sales and Marketing HIV, Janssen, NHS, Symtuza, pharma
Great news for HIV patients in the UK as Janssen reveals that NHS England will provide critical funding for its …
Novo Nordisk cuts 650 roles around the world in R&D restructure
October 1, 2018Manufacturing and Production, Sales and Marketing China, Denmark, Novo Nordisk, UK, US, pharma
Novo Nordisk has announced a wave of jobs cuts as part of a global restructure of its $1 billion R&D …
Antibody therapy supresses HIV for months after treatment, study shows
October 1, 2018Sales and Marketing HIV, immunology, immunotherapy, nature, research
Researchers from the New York City based Rockefeller University have developed a novel immunotherapy, which is capable of suppressing HIV …
Roche acquires immuno-oncology biotech Tusk in €655m deal
October 1, 2018Sales and Marketing Droia, Roche, Tusk, immuno-oncology, immunology, oncology
Swiss multinational Roche has acquired the privately held immuno-oncology company Tusk Therapeutics in a deal that could be worth up …
Ipsen appoints two leading R&D experts in bid to strengthen oncology arm
September 28, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, R&D, development, ipsen, oncology, research
French pharma firm Ipsen has announced the appointment of Dr. Yan Moore as Senior Vice President, Head of Oncology Therapeutic …
Top Ten most popular articles on Pharmafile.com this week
September 28, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, NHS, Novartis, pharma
Life expectancy was a key topic this week, as it emerged that growth has stalled and even fallen in areas …
Novartis strike $40m deal with Chinese firm Cellular Biomedicine
September 28, 2018Medical Communications CAR T, CAR-T, China, Kymriah, Novartis, cellular biomedicine, prc
Swiss multinational Novartis have paired up with Chinese drugmaker Cellular Biomedicine (CBMG) in order to manufacture CAR-T therapy Kymriah in …
Gilead to release generic versions of hep C meds over a decade before patent expiry
September 28, 2018Medical Communications, Sales and Marketing Epclusa, Gilead, generics, harvoni, hepatitis C, pharma
Gilead has announced its intention to undercut itself by releasing generic versions of its blockbuster drugs for the treatment of …
UK government accused of using Brexit to avoid antimicrobial resistance ruling
September 28, 2018Medical Communications AMR, Antibiotics, UK, WHO, antimicrobial resistance, farming, politics
The British government has been accused of using Brexit to avoid implementing new EU legislation preventing powerful antibiotics from be …
Percentage of life sciences professionals using blockchain has tripled since 2017
September 27, 2018Medical Communications blockchain, pharma, pistoia alliance, technology
A survey conducted by The Pistoia Alliance, a not-for-profit coalition of life science companies, vendors, publishers and academic groups, has …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
